NCT07133828View on ClinicalTrials.gov

A Study to Learn About the Safety of BIIB142 and How it is Processed in the Body of Healthy Adult Participants Aged 18 to 55 Years Old

PHASE1RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 29, 2025

Primary Completion Date

August 6, 2026

Study Completion Date

August 6, 2026

Conditions
Healthy Volunteer
Interventions
DRUG

BIIB142

Administered Orally

DRUG

BIIB142-Matching Placebo

Administered Orally

Trial Locations (1)

89113

RECRUITING

PPD Development, LP, Las Vegas

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY